Profile | GDS2987 / GI_26024196-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 67.3 | 73 |
GSM215244 | HMVEC_vehicle_rep2 | 61 | 71 |
GSM215253 | HMVEC_vehicle_rep3 | 68.8 | 73 |
GSM215254 | HMVEC_atorvastatin_rep1 | 55.6 | 70 |
GSM215282 | HMVEC_atorvastatin_rep3 | 49.2 | 67 |
GSM215344 | HMVEC_atorvastatin_rep2 | 67.4 | 72 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 82.5 | 73 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 58.3 | 68 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 83.9 | 72 |
GSM215294 | HMVEC_SLx2119_rep1 | 74.7 | 74 |
GSM215295 | HMVEC_SLx2119_rep2 | 56.3 | 68 |
GSM215296 | HMVEC_SLx2119_rep3 | 38.2 | 53 |
GSM215297 | PASMC_vehicle_rep1 | 9.1 | 14 |
GSM215298 | PASMC_vehicle_rep2 | 22.4 | 34 |
GSM215310 | PASMC_vehicle_rep3 | 22.1 | 34 |
GSM215311 | PASMC_atorvastatin_rep1 | 21.5 | 36 |
GSM215312 | PASMC_atorvastatin_rep2 | 21.8 | 34 |
GSM215313 | PASMC_atorvastatin_rep3 | 72.1 | 68 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 28.5 | 44 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 8.5 | 15 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 22.7 | 39 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 28.3 | 53 |
GSM215331 | Fibroblasts_vehicle_rep2 | 11.2 | 31 |
GSM215332 | Fibroblasts_vehicle_rep3 | ||
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 27.6 | 57 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 48.6 | 67 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 16.9 | 48 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 23.9 | 57 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 4.3 | 13 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 21.3 | 52 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 13.4 | 36 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 13.7 | 33 |